Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-24-110059
Filing Date
2024-09-27
Accepted
2024-09-27 16:46:57
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 prospectussupplementsep2.htm 424B5 429116
2 GRAPHIC img224665463_0.jpg GRAPHIC 5584
3 GRAPHIC img224665463_1.jpg GRAPHIC 4619
4 GRAPHIC img224665463_2.jpg GRAPHIC 5584
  Complete submission text file 0000950170-24-110059.txt   452530
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-280585 | Film No.: 241335605
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)